NCT00345202View on ClinicalTrials.gov

Short Term Effects of HMG-CoA Reductase Inhibition (Atorvastatin)on Renal Hemodynamics, Tubular Function and Vasoactive Hormones on Healthy Subjects

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

February 28, 2005

Study Completion Date

February 28, 2005

Conditions

Healthy

Interventions

DRUG

HMG-CoA reductase inhibition (atorvastatin)

Trial Locations (1)

7500

Medical research unit, Department of medicin, Holstebro Sygehus, Holstebro

All Listed Sponsors

lead

Regional Hospital Holstebro

OTHER

NCT00345202 - Short Term Effects of HMG-CoA Reductase Inhibition (Atorvastatin)on Renal Hemodynamics, Tubular Function and Vasoactive Hormones on Healthy Subjects | Biotech Hunter | Biotech Hunter